ATE132754T1 - Coccidiosis-impfstoff - Google Patents

Coccidiosis-impfstoff

Info

Publication number
ATE132754T1
ATE132754T1 AT87111820T AT87111820T ATE132754T1 AT E132754 T1 ATE132754 T1 AT E132754T1 AT 87111820 T AT87111820 T AT 87111820T AT 87111820 T AT87111820 T AT 87111820T AT E132754 T1 ATE132754 T1 AT E132754T1
Authority
AT
Austria
Prior art keywords
gametocytes
eimeria
gametocyte
vitro
development
Prior art date
Application number
AT87111820T
Other languages
English (en)
Inventor
Michael Wallach
Thea Pugatsch
David Mencher
Original Assignee
Chilwalner Partnership
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chilwalner Partnership filed Critical Chilwalner Partnership
Application granted granted Critical
Publication of ATE132754T1 publication Critical patent/ATE132754T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT87111820T 1986-08-14 1987-08-14 Coccidiosis-impfstoff ATE132754T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89661186A 1986-08-14 1986-08-14

Publications (1)

Publication Number Publication Date
ATE132754T1 true ATE132754T1 (de) 1996-01-15

Family

ID=25406502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87111820T ATE132754T1 (de) 1986-08-14 1987-08-14 Coccidiosis-impfstoff

Country Status (10)

Country Link
EP (1) EP0256536B1 (de)
JP (3) JP2617946B2 (de)
AT (1) ATE132754T1 (de)
AU (1) AU633244B2 (de)
CA (1) CA1340838C (de)
DE (1) DE3751670T2 (de)
ES (1) ES2084576T3 (de)
GR (1) GR3019619T3 (de)
IL (2) IL83523A (de)
ZA (1) ZA876027B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496550A (en) * 1986-08-14 1996-03-05 Chilwalner Method of reducing the output of Eimeria oocysts from a newborn chick
ZA894726B (en) * 1988-06-27 1990-03-28 Akzo Nv Coccidiosis vaccine
NZ232372A (en) * 1989-02-10 1993-04-28 Merck & Co Inc Glycolipid-linked membrane-associated immunogens of eimeria useful in immunising poultry against coccidiosis
US6008342A (en) * 1991-07-12 1999-12-28 Roche Vitamins Inc. DNA encoding eimeria antigen
US5403581A (en) * 1991-07-12 1995-04-04 Hoffmann-La Roche Inc. Coccidiosis vaccines
NZ272945A (en) * 1994-09-16 1997-12-19 Akzo Nobel Nv Eimeria t-lymphocyte stimulating protein and coding sequence, its production and use
DE19828322A1 (de) * 1998-06-25 1999-12-30 Hoechst Roussel Vet Gmbh Coccidienvakzine, Verfahren zu ihrer Herstellung und ihre Verwendung
NZ500033A (en) * 1998-10-07 2001-06-29 Akzo Nobel Nv Hydrophilic eimeria polypeptides for use as coccidiosis vaccines
ZA200400479B (en) 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
RU2004103468A (ru) 2001-07-06 2005-04-20 Абик Байолоджикал Лэборетериз Тева Лтд. (Il) Нуклеиновые кислоты, кодирующие рекомбинантный 250 к-да-антиген спорозоитов/мерозоитов eimeria maxima, и их применения
US9933425B2 (en) * 2014-04-10 2018-04-03 MEP Equine Solutions LLC Method for the quantification of parasite eggs in feces
CN113528348B (zh) * 2021-08-17 2022-04-22 中国农业科学院兰州兽医研究所 一种分离艾美尔球虫小配子的方法和应用
CN114058511A (zh) * 2021-11-30 2022-02-18 中国农业科学院兰州兽医研究所 一种利用dna探针分离球虫小配子的方法
CN117958248A (zh) * 2024-01-29 2024-05-03 中国科学院西北高原生物研究所 一种利用艾美耳球虫防控高原鼠兔的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2849226A1 (de) 1977-11-14 1979-05-17 Unilever Nv Verfahren zur wachstumsfoerderung von gefluegel, mittel zu seiner durchfuehrung und deren herstellung
EP0135712A3 (de) 1983-08-19 1987-05-27 American Cyanamid Company Gegen Sporozoiten von Eimeria Spp. reaktive monoklonale Antikörper und Antigene
EP0135073A3 (de) 1983-08-19 1987-05-27 American Cyanamid Company Gegen Merozoiten von Eimeria Spp. reaktive monoklonale Antikörper und Antigene
JPS6048924A (ja) 1983-08-24 1985-03-16 Takeda Chem Ind Ltd 骨粗鬆症治療剤
CA1340520C (en) 1984-06-05 1999-05-04 Karel Z. Newman Jr. Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix

Also Published As

Publication number Publication date
JPS63233928A (ja) 1988-09-29
ES2084576T3 (es) 1996-05-16
EP0256536A3 (en) 1989-11-02
JP2769313B2 (ja) 1998-06-25
EP0256536B1 (de) 1996-01-10
JP2617946B2 (ja) 1997-06-11
EP0256536A2 (de) 1988-02-24
IL108419A0 (en) 1994-04-12
CA1340838C (en) 1999-12-07
AU633244B2 (en) 1993-01-28
GR3019619T3 (en) 1996-07-31
AU7712187A (en) 1988-05-19
IL83523A (en) 1994-10-21
DE3751670D1 (de) 1996-02-22
JPH09117282A (ja) 1997-05-06
JPH09118700A (ja) 1997-05-06
DE3751670T2 (de) 1996-10-24
ZA876027B (en) 1988-04-27

Similar Documents

Publication Publication Date Title
ATE132754T1 (de) Coccidiosis-impfstoff
Dubois et al. Protective immunization of the squirrel monkey against asexual blood stages of Plasmodium falciparum by use of parasite protein fractions.
Braun-Breton et al. In vivo time course of synthesis and processing of major schizont membrane polypeptides in Plasmodium falciparum
PT77515B (en) Immunogenic protein or peptide complex method of producing said complex and use thereof as an immune stimulant and as a vaccine
ATE127345T1 (de) Stressproteine und verwendungen dafür.
DK190387A (da) Vaccine
IT1223780B (it) Metodo di separazione centrifuga del sangue
EP0283505A4 (de) Impfstoff und verfahren zur herstellung.
PT82975B (pt) Processo de preparacao do antigenio peptidico imunogenico correspondente a proteina circunsporozoito do plasmodium vivax e de vacina contra a malaria
EP0423315A4 (en) Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine
FI896039A7 (fi) Harvinaisen maametallin oksidi, jolla on uusia morfologisia piirteitä ja sen valmistusmenetelmä
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
OA09037A (en) Prevention and treatement of retroviral disease.
IT1198233B (it) Metodo per la determinazione di anticorpi antisporozoita di p. falciparum nel sangue umano
ATE115861T1 (de) Verwendung von adenylzyclase als vakzin gegen bordetella.
MY104081A (en) Rhoptry membrane antigen of plasmodium falciparum.
AU6687786A (en) Asexual blood stage antigens of plasmodium falciparum
IL108419A (en) Proteinaceous extract derived from eimeria maxima gametocytes and vaccines against eimeria maxima containing the same
IL83231A0 (en) Small molecular weight antigen of plasmodium falciparum,antibodies directed thereto,purification and detection of said antigen
GB2220943A (en) Rhoptry antigen of plasmodium falciparum
DK362087D0 (da) Method for a rapid and sensitive detection of early appearing antibodies against retroviruses, as well as igg antibodies against certain retroviruses
AU7632191A (en) Asexual blood stage antigens of plasmodium falciparum
DK541286D0 (da) Fermentationsmetoder for hepatitis-vaccinefremstilling
CS370187A1 (en) Polyvalent inactivated adsorbate vaccine against foals' infective bronchopneumonie and method of its preparation
IT8929567V0 (it) Metodo esemplificato di taglio e cucito denominato: "la multiarte".

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time